Follow
Scott C. Morgan
Scott C. Morgan
Associate Professor, Division of Radiation Oncology, University of Ottawa
Verified email at toh.ca - Homepage
Title
Cited by
Cited by
Year
Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
RC Chen, RB Rumble, DA Loblaw, A Finelli, B Ehdaie, MR Cooperberg, ...
Journal of Clinical Oncology 34 (18), 2182-2190, 2016
3362016
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised …
DH Brand, AC Tree, P Ostler, H van der Voet, A Loblaw, W Chu, D Ford, ...
The Lancet Oncology 20 (11), 1531-1543, 2019
2832019
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative …
TJ Whelan, JA Julian, TS Berrang, D Kim, I Germain, AM Nichol, M Akra, ...
The Lancet 394 (10215), 2165-2172, 2019
2272019
Hypofractionated radiation therapy for localized prostate cancer: An ASTRO, ASCO, and AUA evidence-based guideline
SC Morgan, K Hoffman, DA Loblaw, MK Buyyounouski, C Patton, ...
Journal of Clinical Oncology 36 (34), 3411-3430, 2018
1412018
Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO, and AUA evidence-based guideline
SC Morgan, K Hoffman, DA Loblaw, MK Buyyounouski, C Patton, ...
Practical radiation oncology 8 (6), 354-360, 2018
1402018
Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: a systematic review and meta-analysis
SC Morgan, TS Waldron, L Eapen, LA Mayhew, E Winquist, H Lukka, ...
Radiotherapy and Oncology 88 (1), 1-9, 2008
1002008
Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: dosimetric evaluation
JM Caudrelier, SC Morgan, L Montgomery, M Lacelle, B Nyiri, ...
Radiotherapy and Oncology 90 (1), 99-105, 2009
902009
Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta‐analysis
N Gandhi, S Krishna, CM Booth, RH Breau, TA Flood, SC Morgan, ...
BJU international 122 (5), 744-753, 2018
632018
Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO and AUA evidence-based guideline
SC Morgan, K Hoffman, DA Loblaw, MK Buyyounouski, C Patton, ...
The Journal of urology 201 (3), 528-534, 2019
622019
Local treatment of metastatic cancer—killing the seed or disturbing the soil?
SC Morgan, CC Parker
Nature reviews Clinical oncology 8 (8), 504-506, 2011
492011
Sequencing of androgen-deprivation therapy with external-beam radiotherapy in localized prostate cancer: A phase III randomized controlled trial
S Malone, S Roy, L Eapen, C E, R MacRae, G Perry, J Bowen, R Samant, ...
Journal of Clinical Oncology 38 (6), 593, 2020
472020
CT assessment of conjugate eye deviation in acute stroke
JE Simon, SC Morgan, JHW Pexman, MD Hill, AM Buchan
Neurology 60 (1), 135-7, 2003
452003
Initial management of noncastrate advanced, recurrent, or metastatic prostate cancer: ASCO guideline update
KS Virgo, RB Rumble, R de Wit, DS Mendelson, TJ Smith, ME Taplin, ...
Journal of Clinical Oncology 39 (11), 1274-1305, 2021
432021
Bone health and bone-targeted therapies for nonmetastatic prostate cancer: a systematic review and meta-analysis
SMH Alibhai, K Zukotynski, C Walker-Dilks, U Emmenegger, A Finelli, ...
Annals of internal medicine 167 (5), 341-350, 2017
422017
Prostate radiotherapy with adjuvant androgen deprivation therapy (ADT) improves metastasis-free survival compared to neoadjuvant ADT: An individual patient meta-analysis
DE Spratt, S Malone, S Roy, S Grimes, L Eapen, SC Morgan, J Malone, ...
Journal of Clinical Oncology 39 (2), 136-144, 2021
412021
Stereotactic radiotherapy for oligoprogression in metastatic renal cell cancer patients receiving tyrosine kinase inhibitor therapy: a phase 2 prospective multicenter study
P Cheung, S Patel, SA North, A Sahgal, W Chu, H Soliman, B Ahmad, ...
European Urology 80 (6), 693-700, 2021
362021
Bone health and bone-targeted therapies for prostate cancer: a programme in evidence-based care—cancer care ontario clinical practice guideline
SMH Alibhai, K Zukotynski, C Walker-Dilks, U Emmenegger, A Finelli, ...
Clinical Oncology 29 (6), 348-355, 2017
352017
Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters
SF Riches, GS Payne, NM Desouza, D Dearnaley, VA Morgan, ...
The British journal of radiology 87 (1037), 20130813, 2014
342014
Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters
SF Riches, GS Payne, VA Morgan, D Dearnaley, S Morgan, M Partridge, ...
European Radiology 25 (5), 1247-1256, 2015
332015
Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guideline
J Salerno, A Finelli, C Morash, SC Morgan, N Power, N Schieda, ...
Canadian Urological Association Journal 10 (9-10), E332, 2016
292016
The system can't perform the operation now. Try again later.
Articles 1–20